Does SORAFENIB Cause Malignant neoplasm progression? 219 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 219 reports of Malignant neoplasm progression have been filed in association with SORAFENIB (sorafenib). This represents 2.0% of all adverse event reports for SORAFENIB.
219
Reports of Malignant neoplasm progression with SORAFENIB
2.0%
of all SORAFENIB reports
65
Deaths
40
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SORAFENIB?
Of the 219 reports, 65 (29.7%) resulted in death, 40 (18.3%) required hospitalization, and 8 (3.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SORAFENIB. However, 219 reports have been filed with the FAERS database.
What Other Side Effects Does SORAFENIB Cause?
Hepatocellular carcinoma (1,665)
Diarrhoea (1,611)
Off label use (1,587)
Fatigue (1,041)
Palmar-plantar erythrodysaesthesia syndrome (1,040)
Decreased appetite (906)
Death (904)
Asthenia (777)
Nausea (716)
Rash (613)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SORAFENIB Alternatives Have Lower Malignant neoplasm progression Risk?
SORAFENIB vs SORGHUM HALEPENSE POLLEN
SORAFENIB vs SOTAGLIFLOZIN
SORAFENIB vs SOTALOL
SORAFENIB vs SOTATERCEPT
SORAFENIB vs SOTATERCEPT-CSRK